AZD-1222/elasomeran/tozinameranRetinal vein occlusion

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2012卷 / 1期

关键词：

D O I：

10.1007/s40278-024-60729-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[31] Azd-1222/elasomeran/tozinameranAcute kidney disease: 27 case reports
Reactions Weekly, 2023, 1981 (1) : 85 - 85
[32] Azd-1222/elasomeran/tozinameranCutaneous adverse reactions: 19 case reports
Reactions Weekly, 2023, 1941 (1) : 90 - 90
[33] AZD-1222/elasomeran/tozinameranVarious allergic reactions: 28 case reports
Reactions Weekly, 2023, 1964 (1) : 95 - 95
[34] Azd-1222/mrna-1273/tozinameranRetinal vascular event: 6 case reports
Reactions Weekly, 2021, 1886 (1) : 87 - 87
[35] Azd-1222/elasomeran/tozinameranPemphigus foliaceous and pemphigus vulgaris: 5 case reports
Reactions Weekly, 2023, 1948 (1) : 96 - 96
[36] AZD-1222/elasomeran/tozinameranFever, weakness and cerebral venous thrombosis leading to death
Reactions Weekly, 2024, 1999 (1) : 75 - 75
[37] AZD-1222/Elasomeran/TozinameranImmune-mediated diseases: 7 case reports
Reactions Weekly, 2024, 2035 (1) : 100 - 100
[38] Azd-1222/tozinameranBranch retinal vein occlusion, central retinal vein occlusion and cystoid macular oedema: 5 case reports
Reactions Weekly, 2022, 1915 (1) : 90 - 90
[39] AZD-1222/tozinameranAnaphylaxis
Reactions Weekly, 2024, 2001 (1) : 65 - 65
[40] AZD-1222/tozinameranSub-macular haemorrhage and retinal vein occlusion: 20 case reports
Reactions Weekly, 2022, 1919 (1) : 133 - 133

← 1 2 3 4 5 →